Beijing Balance Medical Technology Co., Ltd.

  • Market Cap: Large Cap
  • Industry: Pharmaceuticals & Biotechnology
  • ISIN: CNE100005X15
CNY
118.21
-1.15 (-0.96%)
  • Price Points
  • Score
  • Mojo Parameters
  • Total Return
  • News and Corporate Actions
  • Key factors
  • Shareholding
  • Financials
  • CompanyCV
stock-recommendationAnnual Results
Results Snapshot
Figures in Million
Consolidate Annual Results
Dec'24
Dec'23
Dec'22
Dec'21
Dec'20
Dec'19
Dec'18
Net Sales
497.68
368.53
293.46
250.59
180.86
145.26
109.83
Other Operating Income
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Total Operating income
497.68
368.53
293.46
250.59
180.86
145.26
109.83
Raw Material Cost
81.40
50.74
36.54
34.61
24.31
17.79
14.67
Purchase of Finished goods
0.00
0.00
0.00
0.00
0.00
0.00
0.00
(Increase) / Decrease In Stocks
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Employee Cost
147.03
127.05
128.93
135.52
74.21
29.15
26.01
Power Cost
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Manufacturing Expenses
0.53
0.46
0.14
0.17
0.04
0.04
0.02
Selling and Distribution Expenses
151.80
129.09
122.65
129.40
83.17
47.25
46.47
Other Expenses
-1.34
-3.74
-7.63
-7.92
-4.79
-1.66
-1.60
Total Expenditure (Excl Depreciation)
367.38
269.90
212.00
220.47
133.86
77.63
71.14
Operating Profit (PBDIT) excl Other Income
130.29999999999998
98.6
81.5
30.099999999999998
47
67.6
38.7
Other Income
20.05
20.85
23.92
18.84
18.99
5.36
2.76
Operating Profit (PBDIT)
175.96
133.70
112.75
56.36
71.66
78.79
47.47
Interest
0.53
0.46
0.14
0.17
0.04
0.04
0.02
Exceptional Items
0.74
1.00
0.89
0.97
0.34
0.00
-0.19
Gross Profit (PBDT)
416.28
317.79
256.92
215.98
156.55
127.47
95.17
Depreciation
25.39
14.23
7.36
7.39
5.67
5.81
6.01
Profit Before Tax
150.79
120.02
106.14
49.76
66.29
72.95
41.25
Tax
18.64
10.61
11.74
-1.51
10.37
10.06
8.11
Provisions and contingencies
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Profit After Tax
146.33
115.21
95.13
51.20
56.53
63.08
33.40
Extraordinary Items
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Prior Period Expenses
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Other Adjustments
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Net Profit
146.33
115.21
95.13
51.20
56.53
63.08
33.40
Share in Profit of Associates
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Minority Interest
-14.19
-5.80
-0.73
0.06
-0.61
-0.20
-0.26
Other related items
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Consolidated Net Profit
132.14
109.41
94.39
51.26
55.92
62.89
33.14
Equity Capital
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Face Value
1.0
1.0
1.0
1.0
1.0
1.0
1.0
Reserves
1,252.60
1,194.61
1,101.45
989.51
837.34
765.68
196.62
Earnings per share (EPS)
1.06
0.84
0.7
0.38
0.42
0.47
0.25
Diluted Earnings per share
1.06
0.84
0.7
0.38
0.42
0.47
0.25
Operating Profit Margin (Excl OI)
26.23%
26.76%
27.76%
12.02%
25.99%
46.55%
35.23%
Gross Profit Margin
35.4%
36.43%
38.67%
22.81%
39.79%
54.22%
43.03%
PAT Margin
29.4%
31.26%
32.42%
20.43%
31.25%
43.43%
30.41%
Public Share Holdings (%)
0.0%
0.0%
0.0%
0.0%
0.0%
0.0%
0.0%
Pledged Promotor Holding (%)
0.0%
0.0%
0.0%
0.0%
0.0%
0.0%
0.0%
Annual Analysis Highlights
stock-summary

Net Sales

YoY Growth in year ended Dec 2024 is 35.06% vs 25.55% in Dec 2023

stock-summary

Consolidate Net Profit

YoY Growth in year ended Dec 2024 is 20.75% vs 15.89% in Dec 2023

stock-summary

Operating Profit (PBDIT) excl Other Income

YoY Growth in year ended Dec 2024 is 38.09% vs 27.14% in Dec 2023

stock-summary

Interest

YoY Growth in year ended Dec 2024 is 0.00% vs 400.00% in Dec 2023

stock-summary

Operating Profit Margin (Excl OI)

YoY Growth in year ended Dec 2024 has fallen from Dec 2023

Compare Annual Results Of Beijing Balance Medical Technology Co., Ltd. With
Markets Mojo
Figures in Million
Consolidate Annual Results
Markets Mojo
Markets Mojo
Change(CNY)
Change(%)
Net Sales
497.68
0
497.68
Other Operating Income
0.00
0.00
0.00
Total Operating income
497.68
0
497.68
Raw Material Cost
81.40
0
81.40
Purchase of Finished goods
0
0
0.00
(Increase) / Decrease In Stocks
0
0
0.00
Employee Cost
147.03
0
147.03
Power Cost
0
0
0.00
Manufacturing Expenses
0.53
0
0.53
Selling and Distribution Expenses
151.80
0
151.80
Other Expenses
-1.34
0.00
-1.34
Total Expenditure (Excl Depreciation)
367.38
0
367.38
Operating Profit (PBDIT) excl Other Income
130.30
0.00
130.30
Other Income
20.05
0
20.05
Operating Profit (PBDIT)
175.96
0
175.96
Interest
0.53
0
0.53
Exceptional Items
0.74
0
0.74
Gross Profit (PBDT)
416.28
0
416.28
Depreciation
25.39
0
25.39
Profit Before Tax
150.79
0
150.79
Tax
18.64
0
18.64
Provisions and contingencies
0
0
0.00
Profit After Tax
146.33
0
146.33
Extraordinary Items
0.00
0
0.00
Prior Period Expenses
0
0
0.00
Other Adjustments
0
0
0.00
Net Profit
146.33
0
146.33
Share in Profit of Associates
0
0
0.00
Minority Interest
-14.19
0
-14.19
Other related items
0.00
0.00
0.00
Consolidated Net Profit
132.14
0
132.14
Equity Capital
0
0
0.00
Face Value
1.00
0
0.00
Reserves
1,252.60
0
1,252.60
Earnings per share (EPS)
1.06
0
1.06
Diluted Earnings per share
1.06
0
1.06
Operating Profit Margin (Excl OI)
26.23%
0%
0.00
26.23%
Gross Profit Margin
35.40%
0%
0.00
35.40%
PAT Margin
29.40%
0%
0.00
29.40%
Public Share Holdings (%)
0%
0%
0.00
0.00%
Pledged Promotor Holding (%)
0%
0%
0.00
0.00%
Annual - Net Sales
Net Sales 49.77 Million
in Dec 2024

Figures in Million
stock-summary

YoY Growth in year ended Dec 2024 is 35.06% vs 25.55% in Dec 2023

Annual - Consolidate Net Profit
Consolidate Net Profit 13.21 Million
in Dec 2024

Figures in Million
stock-summary

YoY Growth in year ended Dec 2024 is 20.75% vs 15.89% in Dec 2023

Annual - Operating Profit (PBDIT)
Operating Profit (PBDIT) 15.59 Million
in Dec 2024

Figures in Million
stock-summary

YoY Growth in year ended Dec 2024 is 38.09% vs 27.14% in Dec 2023

Annual - Interest
Interest 0.05 Million
in Dec 2024

Figures in Million
stock-summary

YoY Growth in year ended Dec 2024 is 0.00% vs 400.00% in Dec 2023

Annual - Operating Profit Margin (Excl OI)
Operating Profit Margin (Excl OI) 26.23%
in Dec 2024

Figures in %
stock-summary

YoY Growth in year ended Dec 2024 has fallen from Dec 2023